Foclivia

Foclivia is a vaccine designed to protect against the H5N1 strain of influenza. It contains inactivated surface antigens to stimulate immune response. Ideal for seasonal flu prevention, this vaccine is administered intramuscularly.

Foclivia is used to prevent influenza caused by the H5N1 strain. It is particularly relevant for individuals at risk of exposure to this specific type of flu virus. The vaccine works by prompting the body's immune system to recognize and fight the influenza virus, providing protection against potential infections.

Common effects of Foclivia may include mild soreness or redness at the injection site. Some individuals might experience temporary fatigue or low-grade fever as the body responds to the vaccine. These effects are generally short-lived and indicate that the immune system is actively building protection against the influenza virus.

Foclivia should be administered by healthcare professionals. Individuals with a history of severe allergic reactions to previous influenza vaccines or any of its components should consult a healthcare provider before receiving this vaccine. It is important to inform your healthcare provider about any current medications or health conditions before vaccination.

Foclivia may interact with certain medications or health conditions. It is advisable to discuss any current medications, including over-the-counter drugs and supplements, with a healthcare provider before receiving the vaccine. Additionally, individuals with weakened immune systems should consult their healthcare provider to determine the appropriateness of this vaccine.